DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xeloda (Capecitabine) - Fatigue - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Fatigue (140)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xeloda (Capecitabine) where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 140   Next >>

Possible Xeloda side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male, weighing 101.7 kg (223.7 pounds)

Reactions: Death, Fatigue, Vomiting

Adverse event resulted in: death

Drug(s) suspected as cause:
Xeloda

Xeloda
    Administration route: Oral
    Indication: Bile Duct Cancer
    Start date: 2012-02-06

Other drugs received by patient: Prochlorperazine; Prochlorperazine



Possible Xeloda side effects in 62 year old female

Reported by a physician from United States on 2012-08-27

Patient: 62 year old female

Reactions: Mucosal Inflammation, Fatigue, Diarrhoea, Mental Status Changes, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda
    Indication: Colorectal Cancer Metastatic

Avastin
    Indication: Colorectal Cancer Metastatic



Possible Xeloda side effects in 69 year old female

Reported by a consumer/non-health professional from Canada on 2012-08-27

Patient: 69 year old female

Reactions: Phlebitis, Breast Cancer, Fatigue, Diarrhoea, Decreased Appetite, Disease Progression

Drug(s) suspected as cause:
Xeloda
    Indication: Product Used FOR Unknown Indication

Tykerb
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Xeloda side effects in 50 year old female

Reported by a physician from Canada on 2012-08-24

Patient: 50 year old female

Reactions: Breast Cancer, Skin Exfoliation, DRY Skin, Paraesthesia, Fatigue, Neoplasm Malignant, Ocular Hyperaemia, Eye Swelling, Lacrimation Increased, Metastases To Central Nervous System

Drug(s) suspected as cause:
Xeloda
    Indication: Product Used FOR Unknown Indication

Tykerb
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Xeloda side effects in 53 year old male

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: 53 year old male

Reactions: Confusional State, Agitation, Dysphagia, Pain, Anaemia, Failure To Thrive, Hypokalaemia, Death, Fatigue, Fluid Intake Reduced, Asthenia, Decreased Appetite, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Nexavar
    Dosage: 400 mg am, 200 mg pm x 21days
    Indication: Colorectal Cancer Metastatic
    Start date: 2012-06-22
    End date: 2012-08-07

Xeloda
    Dosage: 1500 mg am, 1650 mg pm x 14 days
    Indication: Colorectal Cancer Metastatic
    Start date: 2012-06-22
    End date: 2012-08-01

Other drugs received by patient: Roxicodone; Compazine; Ferrous Fumarate; MS Contin; Phenergan HCL; Prinzide; Multi-Vitamin; Compazine



Possible Xeloda side effects in male

Reported by a physician from Korea, Republic of on 2012-08-16

Patient: male, weighing 55.0 kg (121.0 pounds)

Reactions: Pneumonia Fungal, Fatigue, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Xeloda
    Dosage: date of most recent dose prior to sae: 31/jan/2012
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2011-12-21

Herceptin
    Dosage: date of most recent dose prior to sae: 18/jan/2012, 330 mg
    Indication: Gastric Cancer
    Start date: 2011-12-21

Pertuzumab
    Dosage: date of most recent dose prior to sae: 18/jan/2012, 840 mg
    Indication: Gastric Cancer
    Start date: 2011-12-21

Cisplatin
    Dosage: date of most recent dose prior to sae: 18/jan/2012
    Indication: Gastric Cancer
    Start date: 2011-12-21

Other drugs received by patient: Ramosetron; Artemisia Asiatica; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Tramadol HCL; Albumin; Pethidine HCL; Phytonadione; Tranexamic Acid; Potassium Chloride; Potassium Phosphate, Monobasic; Albumin; Fresh Frozen Plasma; Tetracosactrin; Aprepitant; Dexamethasone; Loperamide Oxide; Megestrol Acetate; Potassium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Albumin; Dihydrocodeine Bitartrate INJ; Methylprednisolone Sodium Succinate; Ramosetron; Lactobacillus Acidophilus; Joulie's Solution; Potassium Phosphate, Monobasic; Esomeprazole; Esomeprazole; RED Blood Cells; Aprepitant; Chlorpheniramine Maleate; Ranitidine; Ultracet; Potassium Chloride; Esomeprazole; Pethidine HCL; Remifentanil; Famotidine; Potassium Phosphate, Monobasic; Lenograstim; Bisacodyl; Magnesium Sulfate; Sodium Bicarbonate; Potassium Phosphate, Monobasic; Esomeprazole; Tramadol HCL; Albumin; Morphine HCL; Chlorpheniramine Maleate; Pethidine HCL; Dexamethasone; Potassium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Fresh Frozen Plasma; Ketoprofen; Fentanyl Citrate



Possible Xeloda side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: male, weighing 51.8 kg (113.9 pounds)

Reactions: Peripheral Coldness, Nausea, Skin Exfoliation, Pain in Extremity, Hypoaesthesia, DRY Skin, Erythema, Dysgeusia, Protein Urine, Fatigue, Diarrhoea, Skin Discolouration, Feeling Hot, Decreased Appetite

Drug(s) suspected as cause:
Avastin
    Indication: Colorectal Cancer Metastatic
    Start date: 2012-03-01

Xeloda
    Dosage: 2000mg in morning, 1500 mg in night
    Administration route: Oral
    Indication: Colorectal Cancer Metastatic
    Start date: 2012-03-01
    End date: 2012-07-01



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Australia on 2012-08-16

Patient: female

Reactions: Fatigue, Pain in Extremity, Palmar-Plantar Erythrodysaesthesia Syndrome, Impaired Gastric Emptying, Gait Disturbance, Skin Fissures

Drug(s) suspected as cause:
Xeloda
    Indication: Product Used FOR Unknown Indication

Xeloda



Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-15

Patient: female

Reactions: Fatigue, Arteriospasm Coronary, Rash Pruritic

Drug(s) suspected as cause:
Raltitrexed
    Indication: Product Used FOR Unknown Indication

Xeloda
    Dosage: 2000mg per day
    Indication: Breast Cancer Metastatic
    Start date: 2012-07-20
    End date: 2012-07-23

Tykerb
    Dosage: 1000mg at night
    Indication: Breast Cancer Metastatic
    Start date: 2012-07-20

Other drugs received by patient: Phenergan HCL



Possible Xeloda side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient: male, weighing 55.4 kg (121.9 pounds)

Reactions: Back Pain, Vomiting, Nausea, Musculoskeletal Pain, Abasia, Pain, Ill-Defined Disorder, Malaise, Fatigue, Ageusia, Diarrhoea, Gait Disturbance, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Start date: 2012-05-24
    End date: 2012-05-31

Xeloda
    Administration route: Oral
    Indication: Colon Cancer
    Start date: 2012-05-07
    End date: 2012-05-24

Xeloda
    Administration route: Oral
    Start date: 2012-06-02
    End date: 2012-07-05

Other drugs received by patient: Oxaliplatin



Possible Xeloda side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-13

Patient:

Reactions: Abdominal Pain, Blood Bilirubin Increased, Thrombosis, Anal Examination Abnormal, Hypokalaemia, Fatigue, Proteinuria, Abdominal Distension, Decreased Appetite, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Hyponatraemia, Small Intestinal Obstruction, Hypophosphataemia, Diarrhoea, Alopecia, Dehydration, Neutropenia, Hypertension, Vascular Access Complication

Adverse event resulted in: death

Drug(s) suspected as cause:
Irinotecan Hydrochloride and Irinotecan Hydrochloride
    Dosage: given on day 1
    Indication: Colorectal Cancer Metastatic

Avastin
    Dosage: given on day 1
    Indication: Colorectal Cancer Metastatic

Xeloda
    Dosage: 1000 mg/m2 twice daily for age below 65 years,750 mg/m2 twice daily for age above 65 years
    Administration route: Oral
    Indication: Colorectal Cancer Metastatic



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Mexico on 2012-08-13

Patient: female, weighing 68.0 kg (149.6 pounds)

Reactions: Hysterectomy, Fatigue, Malaise, Palmar-Plantar Erythrodysaesthesia Syndrome, Musculoskeletal Stiffness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-06-21
    End date: 2012-07-05

Xeloda
    Administration route: Oral
    Start date: 2012-08-06



Possible Xeloda side effects in 53 year old male

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: 53 year old male, weighing 80.4 kg (176.8 pounds)

Reactions: Weight Decreased, Constipation, Rectal Cancer Metastatic, Abdominal Discomfort, Fatigue, Frequent Bowel Movements, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-08-08

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: Fatigue, Dyspnoea, General Physical Health Deterioration, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine Tartrate
    Dosage: last dose prior to sae 18 jun 2012
    Indication: Breast Cancer
    Start date: 2012-04-30
    End date: 2012-05-21

Xeloda
    Dosage: last dose prior to sae 22 jun 2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-04-30
    End date: 2012-06-03

Avastin
    Dosage: last dose prior to sae 13/jun/2012
    Indication: Breast Cancer
    Start date: 2012-04-30

Other drugs received by patient: Furosemide; Amlodipine; Amitriptyline HCL; Novalgin



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: female, weighing 70.4 kg (154.8 pounds)

Reactions: Pain in Extremity, Eye Irritation, Skin Exfoliation, Dark Circles Under Eyes, Paraesthesia, Oral Discomfort, Fatigue, Surgery, Arthropathy, LIP Blister, Skin Discolouration, Diarrhoea, Joint Swelling, Systemic Lupus Erythematosus, Unevaluable Event

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in

Reported by a individual with unspecified qualification from Italy on 2012-08-08

Patient:

Reactions: Stomatitis, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Liver Disorder, Mucosal Inflammation, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda
    Indication: Breast Cancer Metastatic

Lapatinib
    Indication: Breast Cancer Metastatic



Possible Xeloda side effects in

Reported by a physician from Spain on 2012-08-07

Patient:

Reactions: Abdominal Pain, Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Death, Fatigue, Diarrhoea, Neutropenia, Hypertension, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Xeloda
    Dosage: drug was used for 14 days every 21 days.
    Administration route: Oral
    Indication: Breast Cancer

Blinded Sorafenib and Blinded Sorafenib
    Administration route: Oral
    Indication: Breast Cancer



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Mexico on 2012-08-06

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Fatigue, Pancreatic Carcinoma, Palmar-Plantar Erythrodysaesthesia Syndrome, Depression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Pancreatic Carcinoma
    Start date: 2011-10-01

Xeloda
    Administration route: Oral
    Start date: 2011-11-01

Other drugs received by patient: Gemcitabine Hydrochloride; Cinnarizine; Aspirin; Irbesartan



Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-08-01

Patient: female

Reactions: Fatigue, Hand Fracture

Drug(s) suspected as cause:
Xeloda
    Dosage: 500 mg 2
    Administration route: Oral
    Indication: Colon Cancer
    Start date: 2011-02-16

Xeloda
    Dosage: 150 mg 3
    Administration route: Oral
    Start date: 2011-02-16



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-01

Patient: female

Reactions: Nausea, Hypotension, Neoplasm Progression, Hepatic Neoplasm, Fatigue, Lung Disorder, Diarrhoea, Dehydration, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-05-18

Xeloda
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Ramipril



Possible Xeloda side effects in 60 year old female

Reported by a physician from Japan on 2012-08-01

Patient: 60 year old female

Reactions: White Blood Cell Count Decreased, Nausea, Neoplasm Progression, Disease Progression, Breast Cancer Metastatic, Fatigue, Diarrhoea, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Xeloda
    Dosage: 3 weeks administration followed by 1 week rest
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2006-11-01
    End date: 2007-06-01

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral

Other drugs received by patient: Herceptin; Herceptin; Anastrozole; Docetaxel; Anastrozole; Anastrozole; Herceptin; Herceptin



Possible Xeloda side effects in male

Reported by a physician from United Kingdom on 2012-07-31

Patient: male, weighing 90.0 kg (198.0 pounds)

Reactions: Fatigue, Chest Pain, Circulatory Collapse

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: last dose prior to sae: 08/feb/2012; last dose: 130 mg
    Indication: Gastric Cancer
    Start date: 2012-02-08

Avastin
    Dosage: last dose prior to sae was updated from 08/feb/2012 to 21/feb/2012; last dose taken: 725 mg; date of
    Indication: Gastric Cancer
    Start date: 2012-02-08

Cisplatin
    Dosage: last dose prior to sae: 21/mar/2012; last dose: 127 mg
    Start date: 2012-02-09

Xeloda
    Dosage: date of most recent dose prior to sae: 04/apr/2012; last dose taken: 1000 in the morning and 1500 in
    Administration route: Oral
    Start date: 2012-02-09

Epirubicin Hydrochloride
    Dosage: last dose: 108 mg; date of most recent dose was updated from 8/feb/2012 to 21/mar/2012
    Indication: Gastric Cancer
    Start date: 2012-02-08

Xeloda
    Dosage: date of most recent dose: 16/feb/2012; dose taken:1500 mg
    Indication: Gastric Cancer
    Start date: 2012-02-08
    End date: 2012-02-08

Xeloda
    Dosage: last dose taken: 725 mg; date of most recent dose: 4/apr/2012
    Administration route: Oral
    Start date: 2012-02-09

Other drugs received by patient: Ondansetron; Amlodipine; Difflam (United Kingdom); Normacol (United Kingdom); Omeprazole; Docusate Sodium; Acetaminophen and Codeine Phosphate; Omeprazole; Acetaminophen and Codeine Phosphate; Cyclizine; Normacol (United Kingdom); Acetaminophen; Nystatin



Possible Xeloda side effects in 57 year old female

Reported by a consumer/non-health professional from United States on 2012-07-31

Patient: 57 year old female, weighing 104.4 kg (229.7 pounds)

Reactions: Fatigue, Neoplasm Malignant, Paraesthesia

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-27

Patient: 60 year old female

Reactions: Confusional State, Fatigue, Diarrhoea, Oedema Peripheral, Fall, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tykerb
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Xeloda
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Corticosteroid (Unk Ingredients)



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-25

Patient: female, weighing 67.2 kg (147.8 pounds)

Reactions: Cold-Stimulus Headache, Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-20

Patient: female, weighing 55.4 kg (121.9 pounds)

Reactions: Abdominal Pain Lower, Breast Cancer Metastatic, Fatigue, Body Temperature Increased, Pain

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Ritalin



Possible Xeloda side effects in 60 year old female

Reported by a physician from Japan on 2012-07-19

Patient: 60 year old female

Reactions: White Blood Cell Count Decreased, Fatigue, Diarrhoea, Nausea, Disease Progression, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Xeloda
    Dosage: three courses
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2006-11-01

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral

Other drugs received by patient: Anastrozole; Herceptin; Docetaxel; Anastrozole; Anastrozole; Herceptin; Herceptin; Herceptin



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-07-19

Patient: female, weighing 49.0 kg (107.8 pounds)

Reactions: Fatigue, Pain in Extremity, Hepatotoxicity, Rash, Disease Progression

Drug(s) suspected as cause:
Xeloda
    Dosage: 1000mg twice per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-05
    End date: 2012-04-02

Lapatinib
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-05
    End date: 2012-04-02

Other drugs received by patient: Oxycodone HCL



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-07-19

Patient: female

Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer

Herceptin
    Indication: Breast Cancer

Xeloda
    Indication: Breast Cancer



Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-18

Patient: female

Reactions: Skin Chapped, Weight Decreased, Swelling Face, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Skin Reaction, LIP Pain, Erythema, Malaise, Fatigue, Oral Pain, Influenza

Drug(s) suspected as cause:
Xeloda
    Dosage: 2000mg per day
    Indication: Breast Cancer
    Start date: 2012-01-01
    End date: 2012-07-06

Tykerb
    Dosage: 1250mg per day
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-01
    End date: 2012-07-06

Other drugs received by patient: Steroid



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014